Filing Flows › Ocugen (OCGN) › Q2 2026 › vs Q2 2025
Ocugen (OCGN) Q2 2026 vs Q2 2025 (year over year)
Ocugen's revenue rose $115K (+8%) from $1.4M in Q2 2025 to $1.5M in Q2 2026.
Ocugen, Q2 2026: revenue $1.5M (+8% year over year), net loss $24.9M, operating cash flow −$12.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $1.4M | $115K | +8% |
| Net loss | $24.9M | $14.7M | $10.1M | +69% |
| Costs & expenses | $26.4M | $16.1M | $10.3M | +64% |
| Operating costs | $17.9M | $15.2M | $2.8M | +18% |
| Interest & other, net | $8.4M | $944K | $7.5M | +793% |
| Research & development | $10.7M | $8.4M | $2.3M | +27% |
| General & admin | $7.2M | $6.8M | $476K | +7% |
| Operating cash sources | $24.9M | $14.7M | $10.1M | +69% |
| Depreciation | $600K | $600K | $0 | 0% |
| Share-based compensation | $1.8M | $1.8M | −$12K | -0.7% |
| Working capital & other | $10.2M | $1.6M | $8.7M | +555% |
| Cash used in operations | $12.2M | $10.7M | $1.5M | +14% |
| Net loss absorbed | $24.9M | $14.7M | $10.1M | +69% |
Questions
How much did Ocugen's revenue grow year over year in Q2 2026?
Ocugen's revenue rose $115K (+8%) from $1.4M in Q2 2025 to $1.5M in Q2 2026.